Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Open accessThe DOI matches its Crossref record; 216 of the 218 references it cites were found in a registry or an index.
Abstract
Abnormalities of the endosomal–lysosomal network (ELN) are a signature feature of Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to AD and that affects endosomes and induces the progressive failure of lysosomes, each of which are directly linked by distinct mechanisms to neurodegeneration. The origins of ELN dysfunction and β‐amyloidogenesis closely overlap, which reflects their common genetic basis, the established early involvement of endosomes and lysosomes in amyloid precursor protein (APP) processing and clearance, and the pathologic effect of certain APP metabolites on ELN functions. Genes that promote β‐amyloidogenesis in AD (APP, PSEN1/2, and APOE4) have primary effects on ELN function. The importance of primary ELN dysfunction to pathogenesis is underscored by the mutations in more than 35 ELN‐related genes that, thus far, are known to cause familial neurodegenerative diseases even though different pathogenic proteins may be involved. In this article, I discuss growing evidence that implicates AD gene–driven ELN disruptions as not only the antecedent pathobiology that underlies β‐amyloidogenesis but also as the essential partner with APP and its metabolites that drive the development of AD, including tauopathy, synaptic dysfunction, and neurodegeneration. The striking amelioration of diverse deficits in animal AD models by remediating ELN dysfunction further supports a need to integrate APP and ELN relationships, including the role of amyloid‐β, into a broader conceptual framework of how AD arises, progresses, and may be effectively therapeutically targeted.—Nixon, R. A. Amyloid precursor protein and endosomal–lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. FASEB J. 31, 2729–2743 (2017). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In summary, oxidative and/or nitrosative damage to multiple proteins, including synaptic proteins is very likely to contribute to the memory problems and other cognitive deficits, reduced ATP availability in neurons, and decreased clearance of abnormal proteins34, creating a “perfect storm” (or sTORm perhaps!) of detrimental cognitive effects in AD9,34,35,41,42.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“In addition to mTOR activation, insulin resistance can also result in neuronal glucose deficiency, with consequent decreased glucose metabolism, impaired ATP production, and dysfunction and/or death7,42”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“Activated mTORC1 is intimately involved in regulation of protein synthesis, autophagy, mitochondrial function, lipogenesis, ketogenesis, and insulin signaling, and is crucially linked to glucose metabolism, where it becomes activated by growth factors, amino acids, and high cellular energy status41,42 (Fig 2).”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“This significant mediator of neuronal death is present in the early stages of AD, and evidence of impaired autophagy is also found in aMCI brain and PCAD brains41–43.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedIntegrative genomics identifies APOE ε4 effectors in Alzheimer's disease
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A. (2013) · Nature · doi:10.1038/nature12415 · Cited by 171
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · cited 1×
“Of particular relevance to AD, lipoprotein receptors mediate glia-derived cholesterol transport within the CNS, which is essential to form and maintain synapses (108).”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Self-citationCellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Research works printed but not linked: 1
- 10.1111/j.1365-2990.2010.01062.x · doi:10.1111/j.1365-2990.2010.01062.x · Paper page
Cited by
Items 301–400 of 407
Protection against Aβ-induced neuronal damage by KU-32: PDHK1 inhibition as important target
Pal, R., Hui, D., Menchen, H., Zhao, H., Mozziconacci, O., Wilkins, H., Blagg, B. S. J., Schöneich, C., Swerdlow, R. H., Michaelis, M. L., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1282855 · Cited by 2
“…and animal models of such diseases, suggests that the cellular protein quality control machinery, including the endosomal-lysosomal network, may be compromised in the aging brain, making brain cells more vulnerable to “proteotoxicity” (Arslan et al., 2006; Gidalevitz et al., 2010; Nixon, 2017).”
BackgroundElder, M. K., Erdjument‐Bromage, H., Oliveira, M. M., Mamcarz, M., Neubert, T. A., & Klann, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.21.260786 · Cited by 2
“…evidence suggests that lysosomal biogenesis is initially upregulated in early stages of AD (Cataldo et al., 1995), before progressive dysfunction throughout the disease process results in the accumulation of enlarged lysosomes, which fail to effectively degrade their contents (Nixon, 2017).”
BackgroundRyan, K. C., Ashkavand, Z., Sarasija, S., Laboy, J. T., Samarakoon, R., & Norman, K. R. (2020) · Research Square · doi:10.21203/rs.3.rs-120594/v1 · Cited by 2
“elegans presenilin ortholog, SEL-12, similar to mutations in human presenilin, results in altered ER calcium signaling, ER-mitochondrial communication and mitochondrial function (5, 12, 16-22).”
BackgroundSarkar, C., Chen, Y., Nguyen, D. P., Weldemariam, M. M., Morel, Y., Mehrabani-Tabari, A. A., Gorny, N., Pettyjohn-Robin, O., Hegdekar, N., Thapa, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.10.675421 · Cited by 2
Biomarkers for Alzheimer's Disease: Early Diagnosis
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Infante-Tadeo, S., & Barber, D. L. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-12-0539 · Cited by 2
“Collectively, these findings suggest that increased pHlys may be a hallmark of neurodegenerative disorders, as previously proposed (Nixon, 2017; Root et al., 2021).”
Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms
Camprubí-Ferrer, L., Yang, Y., Fernández‐Calle, R., Boza‐Serrano, A., García‐Revilla, J., Frontiñán-Rubio, J., & Deierborg, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1729776 · Cited by 3
“Endogenous galectin-3 alters microglial area, mitochondrial content, and motility Microglia are highly mobile cells, and their proper mitochondrial and lysosomal function are key elements of neurodegeneration (Agrawal and Jha, 2020; Nixon, 2017; Lively and Schlichter, 2013).”
Bhuiya, J., Shibly, A. Z., Sheikh, A. M., Tabassum, S., Abdullah, F. B., Fahmida, J., Tamegai, H., Aritake, S., Yano, S., & Nagai, A. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf138 · Cited by 1
Is the Era of One-Size-Fits-All Alzheimer’s Treatment Officially Over?
Verma, S., Kumari, K., Kesharwani, P., Verma, K., Dwivedi, J., Paliwal, S., & Sharma, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02445-1 · Cited by 1
“In AD, early endosomes (Rab5⁺) are enlarged because of trafficking congestion, APP mispro - cessing enhances Aβ formation, and autophagic vesicles are accumulated because of failure in fusion with acidified lysosomes [ 87 ].”
Distribution and Levels of Insulin-like Growth Factor 2 Receptor Across Mouse Brain Cell Types
Gaunt, J. R., Manoj, G., & Alberini, C. M. (2025) · Receptors · doi:10.3390/receptors5010001 · Cited by 2
“…endolysosomal trafficking, distribution and lysosomal functionality support neuronal health and homeostasis but become disrupted in aging and more significantly in several neurodegenerative diseases, contributing to protein aggregation—such as in Alzheimer’s and Parkinson’s diseases [85,89,90].”
Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer’s disease: a review
Ntsapi, C., Weyers, M., Chinheya, R. M., Jim, T., & Matsabisa, M. G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1748368 · Cited by 2
“AVs refer broadly to vesicular structures engaged in the autophagy pathway, including the pre-autophagosomal structures, autophagosomes, lysosomes, or autophagolysosomes (Nixon, 2017; Boland et al., 2008).”
Maaser‐Hecker, A., Zellmer, J. C., Kim, M. M., Bakiasi, G., Maiti, A. K., Curtat, M. P. C., Choi, S. H., Prokopenko, D., Tanzi, R. E., & Bhattacharyya, R. (2026) · Science Advances · doi:10.1126/sciadv.adx2127 · Cited by 4
Bhattacharya, A., Antony, F., Aoki, H., Babu, M., Ferguson, S. S. G., Abd‐Elrahman, K. S., & Duong, F. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00140 · Cited by 4
Lep, M., Plešingrová, K., Sedmík, J., Cesnarikova, S., Feole, M., Bernatík, O., Devoto, V. M. P., Hříbková, H., Černá, K. A., Fojtík, P., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71782 · Cited by 1
“We first focused on endosomal enlargement, a cellularpathologyincreasinglyrecognizedasageneralupstreammech-anism in AD pathogenesis 1,3 as disruption of endosomal function may impair trafficking of key neuronal cargo, including APP, neurotrophic receptors, and lipids, thereby triggering downstream…”
A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegenerationPreprint
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419978 · Cited by 1
Jung, S. H., Roy, R. N., Wang, X., Liu, B., Jaiswal, N., Rai, R. K., Takagi, Y., Gao, C., Zeng, L., Lo, H.-Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.29.573648 · Cited by 1
Raška, J., Satkova, M., Plešingrová, K., Sedmík, J., Cesnarikova, S., Feole, M., Bernatík, O., Devoto, V. M. P., Hříbková, H., Černá, K. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667160 · Cited by 1
“Disruption of endosomal function may impair trafficking of key neuronal cargo, including APP, neurotrophic receptors, and lipids, thereby triggering downstream neurodegenerative cascades [3,6,34].”
Mehrabani-Tabari, A. A., Hegdekar, N., Herb, B. R., Kachi, S. A., Sarkar, C., Thapa, S., Nguyen, D. P., Morel, Y., Weldemariam, M. M., Muller, L., et al. (2025) · Research Square · doi:10.1101/2025.09.04.674092 · Cited by 6
Characterisation of LAMP1- and LAMP2A-positive organelles in neuronsPreprint
Abouward, R., Abdelhafid, A. M., Wilkins, O. G., Lee, S.-Y., Ibrahim, F., Skehel, M. J., Ting, A. Y., Birsa, N., Ule, J., & Schiavo, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.17.676809 · Cited by 1
APOE4 disrupts the central dogma by arresting neuronal proteome dynamicsPreprint
Krogsaeter, E., McKetney, J., Li, L., Liu, I., Richards, A., Subramanyam, V., Yin, K., Gordon, M., Mairal, P. B., Stevenson, E. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738801 · Cited by 3
Amyloid β-peptide interaction with GM1 containing model membrane
Carrotta, R., Librizzi, F., Mangione, M. R., Vilasi, S., & Morán, Ó. (2020) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2020.04.001
Multiscale Analysis of the Amyloid Degradation Toxicity Hypothesis of Alzheimer’s DiseasePreprint
Zaretsky, D. V., & Zaretskaia, M. V. (2020) · Preprints.org · doi:10.20944/preprints202012.0813.v1
“For example, tauopathy in AD is associated with impaired clearance of tau aggregates [139], and can be another consequence of lysosomal deficiency, which by itself stems from amyloidinduced membrane permeability.”
BackgroundInfluentialSasidharakurup, H., Menon, A. S., Sabeen, A. S., & Diwakar, S. (2021) · Advances in intelligent systems and computing · doi:10.1007/978-981-16-4369-9_19
Im, E., Jiang, Y., Stavrides, P. H., Darji, S., Erdjument‐Bromage, H., Thomas, N. A., Bordi, M., Choi, J. Y., Lee, J., & Nixon, R. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4106838
“…studies of human sporadic AD and APP-based AD mouse models have revealed lysosome/autophagy dysfunction to be among the earliest appearing anomalies in AD and the catalyst for varied downstream pathophysiology associated with AD development (Cataldo et al., 1996; Nixon, 2017) (Lee et al. 2022).”
BackgroundSelf-citationFinding Memo: Versatile interactions of the VPS10p receptors in Alzheimer’s diseasePreprint
Salašová, A., Monti, G., Andersen, O. M., & Nykjær, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1650985/v1
Carraro, M. F. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-28012022-104158 · Cited by 2
Marshall, K. E., Mengham, K., Spink, M. C., Vania, L., Pollard, H. J., Darrow, M. C., Duke, E., Harkiolaki, M., & Serpell, L. C. (2022) · Research Square · doi:10.21203/rs.3.rs-2189678/v1
Adaptations of autophagy and lysosomal systems upon membrane damage and pathogenic invasion
Bhattacharya, A. (2023) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.73735
Nery, B. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-29062023-141530
Alternative Hypotheses and Observations that Were Somehow Lost on the Way
Behl, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31570-1_17
The ubiquitin-proteasome system in neurodegenerative diseases: Lessons from mutant ubiquitin
Verheijen, L. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231024lv · Cited by 1
Infante-Tadeo, S., & Barber, D. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.11.628042
Li, S., Wang, Y., Liang, X., & Li, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307403 · Cited by 1
Therapeutic Role of Scutellarein in Neurological Disorders
Kumar, R., Bai, S., Shukla, R., & Naqvi, S. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128336901241125092132
Wright, E. B., Larsen, E. G., Padilla‐Rodriguez, M., Langlais, P. R., & Bhattacharya, M. R. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.01.635992
CPNE7 Regulates Amyloidogenesis Through CAP1 ‐Dependent ADAM10 Translation
Yang, J., Pu, Y., Pan, Q., Wang, L., Li, C., Xie, X., Chen, X., Li, X., Bai, D., Zhu, B., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70026
“However, as BACE1 and ADAM10 do not operate in the same compartment (Endres and Fahrenholz 2012; Zhang and Song 2013) which are associated with Aβ degradation or storage (Nixon 2017), it is likely that other mechanisms may also play a role.”
Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing
Camprubí-Ferrer, L., Soldán-Hidalgo, J., Axell, E., Dell’Eva, M., García-Cruzado, M., García‐Revilla, J., Yang, Y., Fernández‐Calle, R., Larlham, L., Chouhan, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1101/2025.03.17.643790 · Cited by 1
Lysosomal stress induces amyloid-β aggregate release and reactive transformation in human astrocytesPreprint
Goldsworthy, S., Fertan, E., Dyal, P. L., Domoney, S., Livesey, F. J., Klenerman, D., Patani, R., & Hung, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656416
Bartesaghi, R., Chen, X., Johnstone, A. D., Das, U., & Mobley, W. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_19 · Cited by 1
Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
Zhu, H., Cai, M., Chen, D., Sha, J., Du, L., Chen, Y., Liu, S., Zheng, Q., Wei, X., & Bai, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_12
Insights into Proteostasis System in Ageing and Neurodegenerative Disorders
Mishra, Y., Kumar, R., & Netam, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_9
Tian, X., Le, N. N., Zhao, Y., Alawamleh, D., Schwartz, A. M., Meyer, L. F., Helm, E., & Wu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157524
“Impairment of the autophagy-lysosomal pathway has been identified in the brains of patients with tauopathies [12–14] and in various animal tauopathy models [15].”
G3BP1 Maintains Lysosomal Homeostasis to Limit Tau Aggregate AccumulationPreprint
Kimura, T., Saito, R., Okada, M., Matoba, S., Hoshino, A., & Watanabe, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.29.672259
APP ubiquitination by VHL protein is essential for MVB sorting and lysosomal degradation
Shan, C., Cong, R., Xu, X., Li, Y., Tian, Y., Cao, W., Zhao, W., Miao, L., Teng, J., Huang, N., et al. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf033
“Endolysosomal dysfunction, which is related to APP accumulation and A β production in lysosomes, is an early-stage pathogenic symptom of AD (Nixon, 2017 ; Whyte et al., 2017 ).”
Shin, J., Brady, E. S., Chen, C., Lauderdale, K., Agrawal, A., Zhang, Y., Jiang, X., Nambiar, P., Herbert, J., Mallen, D. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.11.687887 · Cited by 1
“69 Lamp1 and Cathepsin B ( Ctsb ) are core components of the lysosomal degradation machinery and were recently identified as critical hub genes of lysosomal dysfunction in AD 70 .”
Prasad, H. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70334 · Cited by 2
“Endosomopathy, characterized by enlarged and dysfunctional endosomes, is among the earliest neuronal pathologies in AD, emerging decades before clinical symptoms and capable of amplifying abnormalities through feedforward loops (Nixon 2017; Small et al. 2017).”
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093090
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093108
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093111
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614915
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093117
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093105
Rimal, S., Li, Y., Vartak, R. S., Geng, J., Tantray, I., Li, S., Huh, S., Vogel, H. S., Glabe, C., Grinberg, L. T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829900
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614924
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614909
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093096
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614918
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614921
Sharoar, M. G., Palko, S. I., Ge, Y., Saido, T. C., & Yan, R. (2021) · Figshare · doi:10.6084/m9.figshare.14903777
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614927
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093093
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093099
Sharoar, M. G., Palko, S. I., Ge, Y., Saido, T. C., & Yan, R. (2021) · Figshare · doi:10.6084/m9.figshare.14903780
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614906
Lambert, E., Saha, O., Landeira, B. S., de Farias, A. R. M., Hermant, X., Carrier, A., Pelletier, A., Gadaut, J., Davoine, L., Dupont, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18093102
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614912
Rab5 hyperactivation: The central hub for endolysosomal dysfunction in Down syndrome
Chen, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00967
“…the endosomal Rab cascade in Down syndrome: While previous studies have shed light on the effects of Rab5 loss-of-function, the consequences of chronic Rab5 hyperactivation, a shared feature in both Alzheimer’s disease (AD) and DS (Nixon, 2017; Chen and Mobley, 2019), have remained less clear.”
Ackley, C., Liau, Z., Arya, S., Antee, T., Cheang, E. S., Knudsen, G. M., Lane‐Donovan, C., Sampognaro, P. J., & Kao, A. W. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00017-6
“Notably, an overabundance of APP fragments has also been shown to impede normal lysosomal activity [25–28].”
Barney, R. M., Quinones-Valdez, G., King, A. J., Amoah, K., Wang, W., & Xiao, X. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.13.705798
“Given that endosomal-lysosomal dysfunction is a hallmark of AD pathology [42], this model suggests a potential mechanistic bridge linking post-transcriptional misregulation in FXS, FXTAS, and AD.”
Bhattacharya, A., Antony, F., Aoki, H., Babu, M., Ferguson, S. S. G., Abd‐Elrahman, K. S., & Duong, F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.24.707828
“The enrichment of both PLD3 and ITM2C observed here supports dysregulation of the endolysosomal pathway as a prominent feature of APP-driven pathology (35).”
Ma, J., Lu, J., Guo, Q.-H., Hua, X., & Xu, J. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014748
Carroll, T., Pfendler, D., Arhayem, H. A., Thoma, R., Müller-Eigner, A., Straut, A., Johnson, G. V. W., & Nehrke, K. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107350
“On a cellular level, mutations in presenilins (PSEN1 and PSEN2) predispose patients to familial AD development and recent research has demonstrated that mutated presenilin leads to the accumulation of dysfunctional lysosomes (Nixon, 2017).”
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
Implication du fragment C99 dans l’avènement des phénotypes pathologiques de la maladie d’Alzheimer
Bourgeois, A. (2019) · theses.fr (ABES) · doi:10.70675/bb8ccf34zec6cz4bb6z82b4z3030b9cb28f7
Linard, M. (2021) · theses.fr (ABES) · doi:10.70675/792b3731z2670z4aedza18ezcd3259857759
Valverde, A. (2020) · theses.fr (ABES) · doi:10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7
Investigating the physiological function of the amyloid precursor protein in Drosophila melanogaster
Kesisoglou, E. (2020) · theses.fr (ABES) · doi:10.70675/691831c4z5491z4cb9zb88az10456e67b7ce
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Studying the role of human Amyloid Precursor Protein (APP) during human cortical neurogenesis
Shabani, K. (2021) · theses.fr (ABES) · doi:10.70675/2deeb337z2d8ez4a8dzaf55z268de3428ac9
Quansah, D. N. K., Halcrow, P. W., Kumar, N., Liang, B., & Geiger, J. D. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261449714 · Cited by 1
“11,14,15 Like other organelles, endolysosomes exhibit stress responses; a process known as lysosomal stress responses (LSR).”
InfluentialErişir, A., Maher, E. E., Anderson, Z., Chawla, S., Hanley, L., Zhao, A., Birisik, K., Toklucu, E. S., & Keskinöz, E. N. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02320-z
APOE4 and INPP5D converge on membrane mechanics to regulate endocytosis in human astrocytesPreprint
Gevorgyan, A. S., Gordon, L. M., Combs, C. A., Lita, A., Yang, L. G., Cuní‐López, C., Root, J. T., Larion, M., Taraska, J. W., & Narayan, P. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726347
Iga, J., Suzuki, J., MATSUSHITA, T., Yoshino, Y., Ozaki, T., Tachibana, A., Kumon, H., Funahashi, Y., Ochi, S., Kuwahara, M., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261453034
Multiomics and proteomic insights into Alzheimer’s disease biology in Down syndrome
Martá-Ariza, M., & Wisniewski, T. R. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2695187
Rabichow, B. E., Nixon, L., Tallant, L., Gibson, K. A., Nascari, D. G., Barnett, J. H., Massa, N., & Fryer, J. D. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71639
Krupa, J. M., Medapati, M. R., Naqvi, A. M., Hallam, R. D., Tsang, A. R., Seah, C., Whitehead, S. N., & Pasternak, S. (2026) · Cells · doi:10.3390/cells15151366
Shim, K. H., Ran, Y., Ryu, D., Moore, B. D., Yook, Y., Amin, P., Liu, X., Afroz, K. F., Martin, C., Beheray, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.21.743990
Jucha, J., Zając, D., Darasz, D., Łukawski, A., Slobozheniuk, L., Bieniak-Pentchev, M., Kaczorek, M., Machnik, K., Dziewięcka, O., & Ziębka, W. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6010
Sun, H., 薛景娇, Gong, H., Luo, W., & Zhao, Y. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147541
Astrocytic synapse engulfment is differentially controlled by APOE genotype
Sekizar, S., Holt, K., Meyers, S., Tzioras, M., King, D., Tulloch, J., Jackson, R. J., & Spires‐Jones, T. L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.09.026
Metadata
- Authors
- Nixon, R. A.
- Affiliations
- Nathan Kline Institute for Psychiatric Research (US)
- Corresponding author
- Nixon, Ralph A.
- ORCID
- Nixon, Ralph A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2017-06-14
- Volume
- 31
- Issue
- 7
- Pages
- 2729-2743
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC6137496
- OpenAlex
- W2728546490
- Cited by
- 400
- References
- 218
- Citations by year
- 2026: 39 · 2025: 55 · 2024: 44 · 2023: 36 · 2022: 50 · 2021: 55 · 2020: 55 · 2019: 34 · 2018: 25 · 2017: 7
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, amyloid precursor protein, lysosomal dysfunction, endosomes, APP processing, presenilin 1, presenilin 2, APOE ε4, tauopathy, synaptic dysfunction, neurodegeneration, familial neurodegenerative disease, animal models of Alzheimer's disease, therapeutic target
- MeSH terms
- Alzheimer Disease, Gene Expression Regulation, Humans, Lysosomes, Endosomes, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.